Attenuation of cardiac dysfunction in polymicrobial sepsis by MicroRNA-146a is mediated via targeting of IRAK1 and TRAF6 expression

Journal of Immunology

Volumn 195, Issue 2, 2015, Pages 672-682

  Gao, Ming ^a   Wang, Xiaohui ^a   Zhang, Xia ^a   Ha, Tuanzhu ^a   Ma, He ^a   Liu, Li ^b   Kalbfleisch, John H ^a   Gao, Xiang ^c   Kao, Race L ^a   Williams, David L ^a   Li, Chuanfu ^a  

^a East Tennessee State University   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 6; LENTIVIRUS VECTOR; LIPOPOLYSACCHARIDE; MICRORNA 146A; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; CYTOKINE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK1 PROTEIN, MOUSE; MICRORNA; MIRN146 MICRORNA, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; HEART DISEASE; HEART EJECTION FRACTION; HEART MUSCLE CELL; LIVER; MACROPHAGE; MACROPHAGE MIGRATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SURVIVAL RATE; TISSUE DISTRIBUTION; ADMINISTRATION AND DOSAGE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CAROTID ARTERY; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HEART FAILURE; HEART MUSCLE; IMMUNOLOGY; INNATE IMMUNITY; INTRAVENOUS DRUG ADMINISTRATION; LENTIVIRINAE; PATHOLOGY; PRIMARY CELL CULTURE; SEPSIS; SIGNAL TRANSDUCTION;

ADMINISTRATION, INTRAVENOUS; ANIMALS; CAROTID ARTERIES; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENETIC VECTORS; HEART FAILURE; IMMUNITY, INNATE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LENTIVIRUS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCARDIUM; MYOCYTES, CARDIAC; NF-KAPPA B; PRIMARY CELL CULTURE; SEPSIS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84936764355     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403155     Document Type: Article

References (41)

1. Mayr, F. B., S. Yende, and D. C. Angus. 2014. Epidemiology of severe sepsis. Virulence 5: 4-11.
2. Gille-Johnson, P., C. Smedman, L. Gudmundsdotter, A. Somell, K. Nihlmark, S. Paulie, J. Andersson, and B. Gårdlund. 2012. Circulating monocytes are not the major source of plasma cytokines in patients with sepsis. Shock 38: 577-583.
3. Fernandes, C. J., Jr., and M. S. C. de Assuncao. 2012. Myocardial dysfunction in sepsis: A large, unsolved puzzle. Crit. Care Res. Pract. DOI: 10.1155/2012/896430.
4. Williams, D. L., T. Ha, C. Li, J. H. Kalbfleisch, J. Schweitzer, W. Vogt, and I. W. Browder. 2003. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med. 31: 1808-1818.
5. Gao, M., T. Ha, X. Zhang, L. Liu, X. Wang, J. Kelley, K. Singh, R. Kao, X. Gao, D. Williams, and C. Li. 2012. Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis. Crit. Care Med. 40: 2390-2399.
6. Avlas, O., R. Fallach, A. Shainberg, E. Porat, and E. Hochhauser. 2011. Toll-like receptor 4 stimulation initiates an inflammatory response that decreases car-diomyocyte contractility. Antioxid. Redox Signal. 15: 1895-1909.
7. Feng, Y., L. Zou, M. Zhang, Y. Li, C. Chen, and W. Chao. 2011. MyD88 and Trif signaling play distinct roles in cardiac dysfunction and mortality during endo-toxin shock and polymicrobial sepsis. Anesthesiology 115: 555-567.
8. Zou, L., Y. Feng, Y. J. Chen, R. Si, S. Shen, Q. Zhou, F. Ichinose, M. Scherrer-Crosbie, and W. Chao. 2010. Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis. Crit. Care Med. 38: 1335-1342.
9. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human ho-mologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
10. Zhang, G., and S. Ghosh. 2001. Toll-like receptor-mediated NF-kB activation: A phylogenetically conserved paradigm in innate immunity. J. Clin. Invest. 107: 13-19.
11. Williams, D. L., T. Ha, C. Li, J. H. Kalbfleisch, J. J. Laffan, and D. A. Ferguson. 1999. Inhibiting early activation of tissue nuclear factor-k B and nuclear factor interleukin 6 with (1→3)-b-D-glucan increases long-term survival in poly-microbial sepsis. Surgery 126: 54-65.
12. Ha, T., C. Lu, L. Liu, F. Hua, Y. Hu, J. Kelley, K. Singh, R. L. Kao, J. Kalbfleisch, D. L. Williams, et al. 2010. TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism. Am. J. Physiol. Heart Circ. Physiol. 298: H984-H991.
13. Gao, M., T. Ha, X. Zhang, X. Wang, L. Liu, J. Kalbfleisch, K. Singh, D. Williams, and C. Li. 2013. The Toll-like receptor 9 ligand, CpG oligodeox-ynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling. J. Infect. Dis. 207: 1471-1479.
14. Sheedy, F. J., and L. A. J. O'Neill. 2008. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann. Rheum. Dis. 67(Suppl. 3): iii50-iii55.
15. Taganov, K. D., M. P. Boldin, and D. Baltimore. 2007. MicroRNAs and immunity: tiny players in a big field. Immunity 26: 133-137.
16. Sonkoly, E., M. Ståhle, and A. Pivarcsi. 2008. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin. Cancer Biol. 18: 131-140.
17. Quinn, S. R., and L. A. O'Neill. 2011. A trio of microRNAs that control Toll-like receptor signalling. Int. Immunol. 23: 421-425.
18. O'Neill, L. A., F. J. Sheedy, and C. E. McCoy. 2011. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11: 163-175.
19. O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10: 111-122.
20. van Rooij, E., W. S. Marshall, and E. N. Olson. 2008. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ. Res. 103: 919-928.
21. Schroen, B., and S. Heymans. 2009. MicroRNAs and beyond: the heart reveals its treasures. Hypertension 54: 1189-1194.
22. Sun, X., B. Icli, A. K. Wara, N. Belkin, S. He, L. Kobzik, G. M. Hunninghake, M. P. Vera, T. S. Blackwell, R. M. Baron, and M. W. Feinberg. 2012. MicroRNA-181b regulates NF-kB-mediated vascular inflammation. J. Clin. Invest. 122: 1973-1990.
23. Taganov, K. D., M. P. Boldin, K.-J. Chang, and D. Baltimore. 2006. NF-kB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486.
24. Li, L., X.-P. Chen, and Y.-J. Li. 2010. MicroRNA-146a and human disease. Scand. J. Immunol. 71: 227-231.
25. Nahid, M. A., M. Satoh, and E. K. Chan. 2011. MicroRNA in TLR signaling and endotoxin tolerance. Cell. Mol. Immunol. 8: 388-403.
26. El Gazzar, M., A. Church, T. Liu, and C. E. McCall. 2011. MicroRNA-146a regulates both transcription silencing and translation disruption of TNF- A during TLR4-induced gene reprogramming. J. Leukoc. Biol. 90: 509-519.
27. Williams, D. L., C. Li, T. Ha, T. Ozment-Skelton, J. H. Kalbfleisch, J. Preiszner, L. Brooks, K. Breuel, and J. B. Schweitzer. 2004. Modulation of the phos-phoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J. Immunol. 172: 449-456.
28. Ha, T., F. Hua, D. Grant, Y. Xia, J. Ma, X. Gao, J. Kelley, D. L. Williams, J. Kalbfleisch, I. W. Browder, et al. 2006. Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice. Am. J. Physiol. Heart Circ. Physiol. 291: H1910-H1918.
29. Collino, F., M. C. Deregibus, S. Bruno, L. Sterpone, G. Aghemo, L. Viltono, C. Tetta, and G. Camussi. 2010. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5: e11803.
30. Wang, X., T. Ha, L. Liu, J. Zou, X. Zhang, J. Kalbfleisch, X. Gao, D. Williams, and C. Li. 2013. Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc. Res. 97: 432-442.
31. Wang, X., T. Ha, J. Zou, D. Ren, L. Liu, X. Zhang, J. Kalbfleisch, X. Gao, D. Williams, and C. Li. 2014. MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. Cardiovasc. Res. 102: 385-395.
32. Cao, Z., Y. Hu, W. Wu, T. Ha, J. Kelley, C. Deng, Q. Chen, C. Li, J. Li, and Y. Li. 2009. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury. Cardiovasc. Res. 84: 442-451.
33. Hua, F., T. Ha, J. Ma, Y. Li, J. Kelley, X. Gao, I. W. Browder, R. L. Kao, D. L. Williams, and C. Li. 2007. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinosi-tide 3-kinase-dependent mechanism. J. Immunol. 178: 7317-7324.
34. Alves-Filho, J. C., A. de Freitas, F. Spiller, F. O. Souto, and F. Q. Cunha. 2008. The role of neutrophils in severe sepsis. Shock 30(Suppl. 1): 3-9.
35. Cavaillon, J.-M., and M. Adib-Conquy. 2005. Monocytes/macrophages and sepsis. Crit. Care Med. 33(12 Suppl.): S506-S509.
36. Raeburn, C. D., C. M. Calkins, M. A. Zimmerman, Y. Song, L. Ao, A. Banerjee, A. H. Harken, and X. Meng. 2002. ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R477-R486.
37. Zhao, J. L., D. S. Rao, M. P. Boldin, K. D. Taganov, R. M. O'Connell, and D. Baltimore. 2011. NF-kB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. USA 108: 9184-9189.
38. Thomas, J. A., S. B. Haudek, T. Koroglu, M. F. Tsen, D. D. Bryant, D. J. White, D. F. Kusewitt, J. W. Horton, and B. P. Giroir. 2003. IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction. Am. J. Physiol. Heart Circ. Physiol. 285: H597-H606.
39. Chen, Z. J. 2012. Ubiquitination in signaling to and activation of IKK. Immunol. Rev. 246: 95-106.
40. Rittirsch, D., M. A. Flierl, and P. A. Ward. 2008. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8: 776-787.
41. Frangogiannis, N. G., C. W. Smith, and M. L. Entman. 2002. The inflammatory response in myocardial infarction. Cardiovasc. Res. 53: 31-47.